China Journal of Leprosy and Skin Diseases ›› 2021, Vol. 37 ›› Issue (9): 605-609.doi: 10.12144/zgmfskin202109605

• Reviews • Previous Articles     Next Articles

Advance of skin adverse reactions caused by molecular targeted anti-tumor drugs

SHI Aixiu1, CAO Shuanglin2   

  1. 1 Department of Dermatology, Suqian First Hospital, Suqian 223800, China; 2 Department of Dermatology, Affiliated Hospital of Nantong University, Nantong 226001, China
  • Online:2021-09-15 Published:2021-08-05
  • Contact: CAO Shuanglin, E-mail: slcao@medmail.com.cn

Abstract: In recent years, the use of targeted anti-tumor drugs has gradually occupied a pivotal position in the treatment of malignant tumors. The widespread application of targeted therapies can significantly improve the survival rate of patients, but the adverse skin reactions(ASR) caused by them are common. Classification and analysis of ASR caused by targeted drugs according to different targets can find commonalities and personalities, and provide new ideas for diagnosis and treatment for dermatologists and oncologists. The types of ASR caused by targeted drugs and their treatment measures of cell membrane-related inhibitors, intracellular signaling inhibitors, and immune checkpoint inhibitors are reviewed in this article.

Key words: targeted therapy, immunotherapy, adverse reactions, skin